Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis

INTRODUCTION: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). Tofacitinib monotherapy was previously shown to inhibit structural damage, reduce clinical signs and symptoms of RA, and improve physical functioning over 24 months in methotrexate (MTX)-naive...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:RMD Open
Main Authors: Fleischmann, Roy M, Huizinga, Tom W J, Kavanaugh, Arthur F, Wilkinson, Bethanie, Kwok, Kenneth, DeMasi, Ryan, van Vollenhoven, Ronald F
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2016
Assuntos:
Rheumatoid Arthritis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4964179/
https://ncbi.nlm.nih.gov/pubmed/27493790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2016-000262
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados